Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Molecular Pharmacology|May 20, 2021
Antidepressants Produce Persistent Gα s-Associated Signaling Changes in Lipid Rafts after Drug WithdrawalNicolas B Senese, Mark M RasenickFrontiers in Pharmacology|November 29, 2018
The Role of G-proteins and G-protein Regulating Proteins in Depressive DisordersNicolas B Senese, Mark M Rasenick, John R TraynorMolecular Psychiatry|June 14, 2018
NMDAR-independent, cAMP-dependent antidepressant actions of ketamineNathan H Wray, Jeffrey M Schappi, Harinder Singh, et al.European Archives of Psychiatry and Clinical Neuroscience|August 19, 2025
Rafting toward a depression biomarkerMark M RasenickThe Journal of Pharmacology and Experimental Therapeutics|December 10, 2009
Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compoundLanqiu Zhang, Mark M RasenickMethods in Cell Biology|August 27, 2013
Heterotrimeric G proteins and microtubulesWitchuda Saengsawang, Mark M RasenickThe FEBS Journal|August 30, 2008
Submembraneous microtubule cytoskeleton: regulation of microtubule assembly by heterotrimeric GproteinsSukla Roychowdhury, Mark M RasenickFrontiers in Pharmacology|December 5, 2022
Gαs, adenylyl cyclase, and their relationship to the diagnosis and treatment of depressionJeffrey M Schappi, Mark M RasenickThe Journal of Biological Chemistry|May 1, 2004
Clathrin-mediated endocytosis of m3 muscarinic receptors. Roles for Gbetagamma and tubulinJuliana S Popova, Mark M RasenickCNS & Neurological Disorders Drug Targets|April 12, 2013
G-protein signaling, lipid rafts and the possible sites of action for the antidepressant effects of n-3 polyunsaturated fatty acidsAndrew H Czysz, Mark M RasenickPageof 7